✦ LIBER ✦

Newer immunmodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis

✍ Scribed by H Nielsen, E Kemp, LJ Petersen, AN Gam, J Dahlager, T Horn, S Larsen…

Book ID: 120707866
Publisher: BioMed Central
Year: 2001
Tongue: English
Weight: 430 KB
Volume: 3
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Newer disease-modifying antirheumatic dr

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis

✍ Samy Suissa; Pierre Ernst; Marie Hudson; Alain Bitton; Abbas Kezouh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Guidelines for the Use of Conventional a

Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

✍ Dr Alejandro Díaz-Borjón 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 244 KB

Presence of significant synovitis in rhe

Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

✍ A. K. Brown; M. A. Quinn; Z. Karim; P. G. Conaghan; C. G. Peterfy; E. Hensor; R. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## Objective More timely and effective therapy for rheumatoid arthritis (RA) has contributed to increasing rates of clinical remission. However, progression of structural damage may still occur in patients who have satisfied remission criteria, which suggests that there is ongoing dise